Abnormal immunological finding in serum, unspecified. R76.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2020 edition of ICD-10-CM R76.9 became effective on October 1, 2019. This is the American ICD-10-CM version of R76.9 - other international versions of ICD-10 R76.9 may differ.
Quantitation of immunoglobulins IgA, IgG, and IgM; IFE interpretation of heavy- and light-chain patterns; serum protein electrophoresis Special Instructions State the patient's age and clinical diagnosis on the test request form.
abnormalities of platelets and thrombocytes ( D69.-) Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
This is the American ICD-10-CM version of E88.09 - other international versions of ICD-10 E88.09 may differ. All neoplasms, whether functionally active or not, are classified in Chapter 2.
A serum immunofixation test measures specific proteins in your blood. It helps to identify certain illnesses that are otherwise hard to detect, such as multiple myeloma, a blood cancer. The test is also known as IFE, immunofixation electrophoresis, or protein electrophoresis.
What is an immunofixation (IFE) blood test? An immunofixation blood test, also known as protein electrophoresis, measures certain proteins in the blood. Proteins play many important roles, including providing energy for the body, rebuilding muscles, and supporting the immune system.
The MUEs for CPT code 86334 (Immunofixation electrophoresis) is changed from 1 to 2 units of service to allow multiple electrophoresis or immunofixation tests to be performed on the same specimen when monitoring multiple myeloma patients.
Protein Electrophoresis Analyzer, SerumTest NameCPT CodesProtein Electrophoresis84165Total Protein84155Pathologist Interpretation84165-26Possible Additional Testing6 more rows
2. Immunofixation identified the proteins unambiguously in all six sera examined, whereas immunoelectrophoresis gave ambiguous results in one of the sera with high protein concentration and in three of the sera with low protein concentration. The superiority of immunofixation resulted from its greater resolution.
This test measures the total amount of immunoglobulin proteins in your blood. It is useful to follow if you are found to have a monoclonal protein in your blood or urine. An increasing amount of M protein over time is one of the criteria for treatment or a change in treatment.
001495: Immunofixation (IFE), Serum and Protein Electrophoresis, Serum | Labcorp.
Serum protein electrophoresis is used to identify patients with multiple myeloma and other serum protein disorders. Electrophoresis separates proteins based on their physical properties, and the subsets of these proteins are used in interpreting the results.
CPT® Code 84155 in section: Protein, total, except by refractometry.
Serum protein electrophoresis uses an electrical field to separate the proteins in the blood serum into groups of similar size, shape, and charge. The total protein test measures the total amount of two classes of proteins found in the fluid portion of your blood. These are albumin and globulin.
Serum total protein, also known as total protein, is a biochemical test for measuring the total amount of protein in serum. Protein in the serum is made up of albumin and globulin. The globulin in turn is made up of α1, α2, β, and γ globulins.
225920: Protein Electrophoresis With Interpretation, Serum | Labcorp.
Abnormality of plasma protein, unspecified 1 R77.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 2 The 2021 edition of ICD-10-CM R77.9 became effective on October 1, 2020. 3 This is the American ICD-10-CM version of R77.9 - other international versions of ICD-10 R77.9 may differ.
The 2022 edition of ICD-10-CM R77.9 became effective on October 1, 2021.
Quantitation of serum immunoglobulins IgA, IgG, and IgM; IFE qualitative interpretation of heavy- and light-chain patterns; serum protein electrophoresis; quantitation of serum free κ and λ light chains plus κ:λ ratio
Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.
Sample should be allowed to clot and the serum separated as soon as possible to prevent hemolysis.
Electrophoresis followed by immunodiffusion against monospecific antisera to immunoglobulin and individual heavy and light chains (IFE); protein electrophoresis on agarose media; turbidimetric quantitation of IgA, IgG, and IgM; turbidimetric quantitation of free κ and λ light chains
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™) recommend the use of serum free light chain assays in the initial diagnostic work-up of multiple myeloma and related disorders.
1. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™) for Multiple Myeloma, Version 1.2011. Fort Washington, Pa: NCCN; 2011.